Full weekend edition + daily archive:
https://burns-media.com/biotech/?utm_source=mastodon&utm_medium=social&utm_campaign=biotech_weekly
Subscribe — free, weekday mornings.
If you also ran to check your prescriptions after listening to this episode, use our “Rx Inspector” tool to look up where your generic drugs were made: https://propublica.org/rx-inspector
For years, the FDA told the public that generics are just as safe and effective as brand-name medications. But ProPublica reporters found that this isn’t always true.
Listen to the first episode of “Paper Trail,” our new podcast. Subscribe: https://www.propublica.org/podcast/what-fda-wont-tell-you-generic-drugs-safety?utm_source=mastodon&utm_medium=social&utm_campaign=mastodon-post
#Southern, midsized cities lead population gains between -
https://kensbookinfo.blogspot.com/p/etc-states.html#49
Is the #Motorola Razr Fold waterproof? -
https://kensbookinfo.blogspot.com/p/infotech.html#29
An #FDA-Authorized Tinnitus Treatment Device -
https://kensbookinfo.blogspot.com/p/24-7-pr.html#145
#Oxfordshire MP calls for vaccine roll-out after student -
https://kensbookinfo.blogspot.com/p/uk.html#7
Has the #University of #Wisconsin Really Abandoned D -
https://kensbookinfo.blogspot.com/p/politics.html#3
View all cultural news https://kensbookinfo.blogspot.com/2026/03/latest-cultural-news.html
Young #Kyrgyzstani wins silver at #Asian Youth #Boxing -
https://kensbookinfo.blogspot.com/p/world-capitals.html#Bishkek
How Tinubu Made Me Drop #Lagos #Governorship Ambition -
https://kensbookinfo.blogspot.com/p/etc.html#Nigeria
#Security will be tight for voting rights rally -
https://kensbookinfo.blogspot.com/p/cities.html#67a
Teach your children truth, not comfort – #FDA Director -
https://kensbookinfo.blogspot.com/p/etc.html#Ghana
Networks spin #Trump’s Xi meeting as weakness despite -
https://kensbookinfo.blogspot.com/p/etc.html#Taiwan
View all the Continents news https://kensbookinfo.blogspot.com/2026/03/latest-news-from-continents.html
Blackstone Products of Providence, Utah is voluntarily recalling certain lots of Blackstone Parmesan Ranch seasoning products because they have the potential to be contaminated with Salmonella. Blackstone’s action is based on a California Dairies, Inc. recall of dry milk powder due to potential Sal
May 14, 2026; Petaluma, CA; — Straus Family Creamery is voluntarily recalling a small number of production runs of select flavors and sizes of its Organic Ice Cream due to the potential presence of metal foreign material. Only the production runs (noted by the “best by” date on package) specified l
📰 BIOTECH CATALYST
Regenxbio outlines accelerated approval path for RGX-202
This could position Regenxbio as a leader in gene therapy for…
In today's briefing →
https://burns-media.com/biotech/archive/2026-05-15?utm_source=mastodon&utm_medium=social&utm_campaign=biotech_resurface
Gregor Nassief named president-elect of #Caribbean Hotel -
https://kensbookinfo.blogspot.com/p/world-capitals.html#Roseau
#FDA blocked melanoma drug as confusion reigned under -
https://kensbookinfo.blogspot.com/p/news.html#9
Claude For #Legal, Clio $500m, #Legal Innovators #California -
https://kensbookinfo.blogspot.com/p/ai.html#11
Where to Buy, Price, #History -
https://kensbookinfo.blogspot.com/p/ireland.html#The42
#Idaho farmers can band together to buy cheaper health -
https://kensbookinfo.blogspot.com/p/etc-states.html#12
View all news from Capitals in the World https://kensbookinfo.blogspot.com/2026/03/latest-news-from-capitals-of-world.html
US Top News and Analysis | Bristol Myers Squibb turns to China to develop new drugs in newest cross-continent collaboration
AI generated summary, Read the full article for complete information.
Bristol Myers Squibb announced a multi‑billion‑dollar partnership with China’s top drugmaker Hengrui Pharma to develop roughly a dozen new medicines, including four experimental compounds that BMS will send to China for early‑stage clinical testing. Unlike typical licensing deals where U.S. firms outsource Chinese discoveries, this reciprocal arrangement has both companies contributing assets and jointly discovering novel drugs, signaling a shift toward a “global mesh” model of R&D. Industry observers note that American and European biopharma firms are increasingly turning to China for faster, cheaper early‑stage research—potentially cutting development time by half and costs by two‑thirds—while later‑stage trials remain U.S.‑centric to satisfy FDA requirements. The deal underscores China’s growing role as a central hub in global drug development rather than merely a source of one‑off molecules.
#BristolMyers #HengruiPharma #Pfizer #Merck #AstraZeneca #EliLilly #MichaelBaran #McKinsey #DealForma #FDA # #LievenVanderVeken
Burns Media
ProPublica
Ken Everett (Ken's Blogspot)
FDA Recall Bot
The Bad Place